BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 31886717)

  • 1. Activin type II receptor ligand signaling inhibition after experimental ischemic heart failure attenuates cardiac remodeling and prevents fibrosis.
    Castillero E; Akashi H; Najjar M; Ji R; Brandstetter LM; Wang C; Liao X; Zhang X; Sperry A; Gailes M; Guaman K; Recht A; Schlosberg I; Sweeney HL; Ali ZA; Homma S; Colombo PC; Ferrari G; Schulze PC; George I
    Am J Physiol Heart Circ Physiol; 2020 Feb; 318(2):H378-H390. PubMed ID: 31886717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activin type II receptor signaling in cardiac aging and heart failure.
    Roh JD; Hobson R; Chaudhari V; Quintero P; Yeri A; Benson M; Xiao C; Zlotoff D; Bezzerides V; Houstis N; Platt C; Damilano F; Lindman BR; Elmariah S; Biersmith M; Lee SJ; Seidman CE; Seidman JG; Gerszten RE; Lach-Trifilieff E; Glass DJ; Rosenzweig A
    Sci Transl Med; 2019 Mar; 11(482):. PubMed ID: 30842316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p38 mitogen-activated protein kinase inhibition decreases TNFalpha secretion and protects against left ventricular remodeling in rats with myocardial ischemia.
    Yin H; Zhang J; Lin H; Wang R; Qiao Y; Wang B; Liu F
    Inflammation; 2008 Apr; 31(2):65-73. PubMed ID: 17943427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
    See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
    J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted inhibition of activin receptor-like kinase 5 signaling attenuates cardiac dysfunction following myocardial infarction.
    Tan SM; Zhang Y; Connelly KA; Gilbert RE; Kelly DJ
    Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1415-25. PubMed ID: 20154262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of TGF-beta1-TAK1-p38 MAPK pathway in spared cardiomyocytes is involved in left ventricular remodeling after myocardial infarction in rats.
    Matsumoto-Ida M; Takimoto Y; Aoyama T; Akao M; Takeda T; Kita T
    Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H709-15. PubMed ID: 16183734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postinfarction gene therapy against transforming growth factor-beta signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure.
    Okada H; Takemura G; Kosai K; Li Y; Takahashi T; Esaki M; Yuge K; Miyata S; Maruyama R; Mikami A; Minatoguchi S; Fujiwara T; Fujiwara H
    Circulation; 2005 May; 111(19):2430-7. PubMed ID: 15867170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Panax Notoginseng Saponins Inhibits Ventricular Remodeling after Myocardial Infarction in Rats Through Regulating ATF3/MAP2K3/p38 MAPK and NF κ B Pathway.
    Ma RF; Chen G; Li HZ; Zhang Y; Liu YM; He HQ; Liu CY; Xie ZC; Zhang ZP; Wang J
    Chin J Integr Med; 2020 Dec; 26(12):897-904. PubMed ID: 33259022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic blockade of ACVR2B ligands attenuates muscle wasting in ischemic heart failure without compromising cardiac function.
    Szabó Z; Vainio L; Lin R; Swan J; Hulmi JJ; Rahtu-Korpela L; Serpi R; Laitinen M; Pasternack A; Ritvos O; Kerkelä R; Magga J
    FASEB J; 2020 Aug; 34(8):9911-9924. PubMed ID: 32427381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of Myostatin Improves Cardiac Function Following Myocardial Infarction.
    Lim S; McMahon CD; Matthews KG; Devlin GP; Elston MS; Conaglen JV
    Heart Lung Circ; 2018 Jun; 27(6):693-701. PubMed ID: 28690022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qiliqiangxin Attenuates Cardiac Remodeling via Inhibition of TGF-β1/Smad3 and NF-κB Signaling Pathways in a Rat Model of Myocardial Infarction.
    Han A; Lu Y; Zheng Q; Zhang J; Zhao Y; Zhao M; Cui X
    Cell Physiol Biochem; 2018; 45(5):1797-1806. PubMed ID: 29510381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiomyocyte-specific overexpression of oestrogen receptor β improves survival and cardiac function after myocardial infarction in female and male mice.
    Schuster I; Mahmoodzadeh S; Dworatzek E; Jaisser F; Messaoudi S; Morano I; Regitz-Zagrosek V
    Clin Sci (Lond); 2016 Mar; 130(5):365-76. PubMed ID: 26608078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Runx1 Deficiency Protects Against Adverse Cardiac Remodeling After Myocardial Infarction.
    McCarroll CS; He W; Foote K; Bradley A; Mcglynn K; Vidler F; Nixon C; Nather K; Fattah C; Riddell A; Bowman P; Elliott EB; Bell M; Hawksby C; MacKenzie SM; Morrison LJ; Terry A; Blyth K; Smith GL; McBride MW; Kubin T; Braun T; Nicklin SA; Cameron ER; Loughrey CM
    Circulation; 2018 Jan; 137(1):57-70. PubMed ID: 29030345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liraglutide improves myocardial fibrosis after myocardial infarction through inhibition of CTGF by activating cAMP in mice.
    Huang DD; Huang HF; Yang Q; Chen XQ
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4648-4656. PubMed ID: 30058704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginsenoside Rg2 attenuates myocardial fibrosis and improves cardiac function after myocardial infarction via AKT signaling pathway.
    Li X; Xiang N; Wang Z
    Biosci Biotechnol Biochem; 2020 Nov; 84(11):2199-2206. PubMed ID: 32706304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the combination of tanshinone IIA and puerarin on cardiac function and inflammatory response in myocardial ischemia mice.
    Gao S; Li L; Li L; Ni J; Guo R; Mao J; Fan G
    J Mol Cell Cardiol; 2019 Dec; 137():59-70. PubMed ID: 31629735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cyclooxygenase-2 improves cardiac function after myocardial infarction in the mouse.
    LaPointe MC; Mendez M; Leung A; Tao Z; Yang XP
    Am J Physiol Heart Circ Physiol; 2004 Apr; 286(4):H1416-24. PubMed ID: 14670812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction.
    Most P; Seifert H; Gao E; Funakoshi H; Völkers M; Heierhorst J; Remppis A; Pleger ST; DeGeorge BR; Eckhart AD; Feldman AM; Koch WJ
    Circulation; 2006 Sep; 114(12):1258-68. PubMed ID: 16952982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alamandine improves cardiac remodeling induced by transverse aortic constriction in mice.
    Silva MM; de Souza-Neto FP; Jesus ICG; Gonçalves GK; Santuchi MC; Sanches BL; de Alcântara-Leonídio TC; Melo MB; Vieira MAR; Guatimosim S; Santos RAS; da Silva RF
    Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H352-H363. PubMed ID: 33124885
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Peng H; Xu J; Yang XP; Kassem KM; Rhaleb IA; Peterson E; Rhaleb NE
    Can J Physiol Pharmacol; 2019 Aug; 97(8):753-765. PubMed ID: 30998852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.